Paul C. Lorigan: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Expanded access programmes: patient interests versus clinical trial integrity

Lorigan, Paul, Ascierto, Paolo A, Dummer, Reinhard, Eggermont, Alexander M, Flaherty, Keith T, Garbe, Claus, Gogas, Helen, Hauschild, Axel, Kefford, Richard F, Kirkwood, John M, Larkin, James, Long, G

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 120 KB

english, 2015

52

Predicting the myelotoxicity of chemotherapy

Sabharwal, Ami, Waters, Rachel, Danson, Sarah, Clamp, Andrew, Lorigan, Paul, Thatcher, Nick, Margison, Geoffrey P., Middleton, Mark R.

Journal:

Melanoma Research

Year:

2011

Language:

english

File:

PDF, 228 KB

english, 2011

53

Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma

Khoja, Leila, Shenjere, Patrick, Hodgson, Clare, Hodgetts, Jackie, Clack, Glen, Hughes, Andrew, Lorigan, Paul, Dive, Caroline

Journal:

Melanoma Research

Year:

2014

Language:

english

File:

PDF, 481 KB

english, 2014

54

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

Howell, Matthew, Lee, Rebecca, Bowyer, Samantha, Fusi, Alberto, Lorigan, Paul

Journal:

Year:

2015

Language:

english

File:

PDF, 373 KB

english, 2015

55

The place of PD-1 inhibitors in melanoma management

Bowyer, Samantha, Lorigan, Paul

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 117 KB

english, 2015

56

MDR-1 Expression in Non-Hodgkin's Lymphomas is Unrelated to Treatment Intensity or Response to Therapy

Finnegan, Maria C.M., Royds, Janice, Goepel, John R., Lorigan, Paul, Hancock, Barry W., Goyns, Malcolm H.

Journal:

Leukemia and Lymphoma

Year:

1995

Language:

english

File:

PDF, 1.05 MB

english, 1995

57

PD-L1 expression as a potential predictive biomarker

Fusi, Alberto, Festino, Lucia, Botti, Gerado, Masucci, Giuseppe, Melero, Ignacio, Lorigan, Paul, Ascierto, Paolo A

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 153 KB

english, 2015

58

Integrating radiotherapy with emerging systemic therapies: lessons from a patient with cerebral radionecrosis, spinal cord myelopathy and radiation pneumonitis

Flaum, Nicola, Lorigan, Paul, Whitfield, Gillian A., Hawkins, Robert E., Pinkham, Mark B.

Journal:

Practical Radiation Oncology

Year:

2015

Language:

english

File:

PDF, 682 KB

english, 2015

59

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

Ugurel, Selma, Röhmel, Joachim, Ascierto, Paolo A., Flaherty, Keith T., Grob, Jean Jacques, Hauschild, Axel, Larkin, James, Long, Georgina V., Lorigan, Paul, McArthur, Grant A., Ribas, Antoni, Robert,

Journal:

European Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 611 KB

english, 2016

60

High-risk cutaneous melanoma follow-up: time for more intensive surveillance?

Davidson, Michael, Lorigan, Paul, Larkin, James

Journal:

Melanoma Management

Year:

2014

Language:

english

File:

PDF, 1.38 MB

english, 2014

61

Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-Analysis

Calman, Lynn, Beaver, Kinta, Hind, Daniel, Lorigan, Paul, Roberts, Chris, Lloyd-Jones, Myfanwy

Journal:

Journal of Thoracic Oncology

Year:

2011

Language:

english

File:

PDF, 427 KB

english, 2011

62

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.

Journal:

Investigational New Drugs

Year:

2016

Language:

english

File:

PDF, 687 KB

english, 2016

63

Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

Festino, Lucia, Botti, Gerardo, Lorigan, Paul, Masucci, Giuseppe V., Hipp, Jason D., Horak, Christine E., Melero, Ignacio, Ascierto, Paolo A.

Journal:

Year:

2016

Language:

english

File:

PDF, 1.24 MB

english, 2016

64

Sequential immunotherapy regimens—expect the unexpected

Serra-Bellver, Patricio, Valpione, Sara, Lorigan, Paul

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 129 KB

english, 2016

65

Vemurafenib-induced nonautoimmune haemolytic anaemia

Fusi, Alberto, Hodgetts, Jackie, Dennis, Mike, Lorigan, Paul

Journal:

Melanoma Research

Year:

2014

Language:

english

File:

PDF, 87 KB

english, 2014

66

Sodium salicylate inhibits TNF-??-induced NF-??B activation, cell migration, invasion and ICAM-1 expression in human melanoma cells

Katerinaki, Efthymia, Haycock, John W., Lalla, Ravindra, Carlson, Kenneth E., Yang, Yifan, Hill, Rebecca P., Lorigan, Paul C., MacNeil, Sheila

Journal:

Melanoma Research

Year:

2006

Language:

english

File:

PDF, 188 KB

english, 2006

67

Dabrafenib and its use in the treatment of metastatic melanoma

Bowyer, Samantha, Lee, Rebecca, Fusi, Alberto, Lorigan, Paul

Journal:

Melanoma Management

Year:

2015

Language:

english

File:

PDF, 2.23 MB

english, 2015

68

Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient

Kaehler, Katharina C., Egberts, Friederike, Lorigan, Paul, Hauschild, Axel

Journal:

Melanoma Research

Year:

2009

Language:

english

File:

PDF, 91 KB

english, 2009

69

The role of chemotherapy in the modern management of melanoma

Lee, Rebecca Jane, Ul-Ain-Tariq, Noor, Fusi, Alberto, Bowyer, Samantha, Lorigan, Paul

Journal:

Melanoma Management

Year:

2014

Language:

english

File:

PDF, 1.48 MB

english, 2014

70

Monitoring neutrophil phagocytosis in lung cancer patients or normal stem cell donors, treated with G-CSF

LAWRY, JOHN, SMITH, M. OLIVIA, LORIGAN, PAUL C.

Journal:

Biochemical Society Transactions

Year:

1997

Language:

english

File:

PDF, 119 KB

english, 1997

71

A Phase I/II Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Small Cell Lung Cancer Patients with Extensive-Stage Disease

Socinski, Mark. A., Kaye, Frederic J., Spigel, David R., Kudrik, Fred J., Ponce, Santiago, Ellis, Peter M., Majem, Margarita, Lorigan, Paul, Gandhi, Leena, Gutierrez, Martin E., Nepert, Dale, Corral,

Journal:

Clinical Lung Cancer

Year:

2016

Language:

english

File:

PDF, 1.51 MB

english, 2016

72

Probing the Local Secondary Structure of Human Vimentin with Electron Spin Echo Envelope Modulation (ESEEM) Spectroscopy

Liu, Lishan, Hess, John, Sahu, Indra D., FitzGerald, Paul G., McCarrick, Robert M., Lorigan, Gary A.

Journal:

Journal of Physical Chemistry B

Year:

2016

Language:

english

File:

PDF, 852 KB

english, 2016

73

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

D’Angelo, Sandra P., Larkin, James, Sosman, Jeffrey A., Lebbé, Celeste, Brady, Benjamin, Neyns, Bart, Schmidt, Henrik, Hassel, Jessica C., Hodi, F. Stephen, Lorigan, Paul, Savage, Kerry J., Miller, Wi

Journal:

Journal of Clinical Oncology

Year:

2017

Language:

english

File:

PDF, 1.03 MB

english, 2017

74

Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

Faivre-Finn, Corinne, Falk, Sally, Ashcroft, Linda, Bewley, Michelle, Lorigan, Paul, Wilson, Elena, Groom, Nicki, Snee, Michael, Fournel, Pierre, Cardenal, Felipe, Bezjak, Andrea, Blackhall, Fiona

Journal:

Year:

2016

Language:

english

File:

PDF, 794 KB

english, 2016

75

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’

Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Eliza

Journal:

British Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 130 KB

english, 2017

76

Immunotherapy: Does adjuvant ipilimumab have little adverse effect on quality of life?

Lorigan, Paul, Green, Adele C.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2017

Language:

english

File:

PDF, 140 KB

english, 2017

77

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis

Ives, Natalie J., Suciu, Stefan, Eggermont, Alexander M.M., Kirkwood, John, Lorigan, Paul, Markovic, Svetomir N., Garbe, Claus, Wheatley, Keith, Bufalino, Rosaria, Cameron, David, Cascinelli, Natale,

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 2.41 MB

english, 2017

78

The role for chemotherapy in the modern management of melanoma

Gupta, Avinash, Gomes, Fabio, Lorigan, Paul

Journal:

Melanoma Management

Year:

2017

Language:

english

File:

PDF, 1.50 MB

english, 2017

79

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

Schachter, Jacob, Ribas, Antoni, Long, Georgina V, Arance, Ana, Grob, Jean-Jacques, Mortier, Laurent, Daud, Adil, Carlino, Matteo S, McNeil, Catriona, Lotem, Michal, Larkin, James, Lorigan, Paul, Neyn

Journal:

Lancet (London, England)

Year:

2017

Language:

english

File:

PDF, 945 KB

english, 2017

80

Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017

Ugurel, Selma, Röhmel, Joachim, Ascierto, Paolo A., Flaherty, Keith T., Grob, Jean Jacques, Hauschild, Axel, Larkin, James, Long, Georgina V., Lorigan, Paul, McArthur, Grant A., Ribas, Antoni, Robert,

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 2.89 MB

english, 2017

81

Dose rationalisation of pembrolizumab and nivolumab using pharmacokinetic modelling and simulation and cost analysis

Ogungbenro, Kayode, Patel, Alkesh, Duncombe, Robert, Nuttall, Richard, Clark, James, Lorigan, Paul

Journal:

Clinical Pharmacology & Therapeutics

Year:

2017

Language:

english

File:

PDF, 5.20 MB

english, 2017

82

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy

Suciu, Stefan, Eggermont, Alexander M. M., Lorigan, Paul, Kirkwood, John M., Markovic, Svetomir N., Garbe, Claus, Cameron, David, Kotapati, Srividya, Chen, Tai-Tsang, Wheatley, Keith, Ives, Natalie, d

Journal:

JNCI Journal of the National Cancer Institute

Year:

2018

Language:

english

File:

PDF, 947 KB

english, 2018

83

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

Grob, Jean Jacques, Schadendorf, Dirk, Lorigan, Paul, Ascierto, Paolo, Larkin, James, Nathan, Paul, Robert, Caroline, Hauschild, Axel, Weber, Jeffrey, Daud, Adil, Hamid, Omid, Dummer, Reinhard, Hansso

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 432 KB

english, 2017

84

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma

Lim, Kok Haw Jonathan, Spain, Lavinia, Barker, Claire, Georgiou, Alexandros, Walls, Gerard, Gore, Martin, Turajlic, Samra, Board, Ruth, Larkin, James M, Lorigan, Paul

Journal:

Year:

2018

Language:

english

File:

PDF, 261 KB

english, 2018

85

Efficacy of Positron Emission Tomography Staging for Small-Cell Lung Cancer: A Systematic Review and Cost Analysis in the Australian Setting

Faivre-Finn, Corinne, Lorigan, Paul

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

86

Management of Chronic Hypotony following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma

Reid, Gerard, Lorigan, Paul, Heimann, Heinrich, Hovan, Marta

Journal:

Ocular Immunology & Inflammation

Year:

2018

Language:

english

File:

PDF, 610 KB

english, 2018

87

Survival of patients with early invasive melanoma down-staged under the new 8 th AJCC edition

von Schuckmann, Lena A., Celia B Hughes, Maria, Lee, Rebecca, Lorigan, Paul, Khosrotehrani, Kiarash, Smithers, B Mark, Green, Adele C.

Journal:

Journal of the American Academy of Dermatology

Year:

2018

Language:

english

File:

PDF, 211 KB

english, 2018

88

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial

Lipplaa, Astrid, Fernandes, Ricardo, Marshall, Andrea, Lorigan, Paul, Dunn, Janet, Myers, Kevin A., Barker, Emily, Newton-Bishop, Julia, Middleton, Mark R., Corrie, Pippa G.

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 373 KB

english, 2018

89

Emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomes

Cooksley, Tim, Higham, Claire, Lorigan, Paul, Trainer, Peter

Journal:

Year:

2018

Language:

english

File:

PDF, 106 KB

english, 2018

90

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial

Larkin, James, Minor, David, D'Angelo, Sandra, Neyns, Bart, Smylie, Michael, Miller, Wilson H., Gutzmer, Ralf, Linette, Gerald, Chmielowski, Bartosz, Lao, Christopher D., Lorigan, Paul, Grossmann, Ken

Journal:

Journal of Clinical Oncology

Year:

2018

File:

PDF, 894 KB

2018

91

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

Tarhini, Ahmad A., Lorigan, Paul, Leachman, Sancy

Journal:

American Society of Clinical Oncology Educational Book

Year:

2017

Language:

english

File:

PDF, 636 KB

english, 2017

92

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

Tarhini, Ahmad A., Lorigan, Paul, Leachman, Sancy

Journal:

American Society of Clinical Oncology Educational Book

Year:

2017

File:

PDF, 636 KB

2017

93

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

Schadendorf, Dirk, Ascierto, Paolo A., Haanen, John, Espinosa, Enrique, Demidov, Lev, Garbe, Claus, Guida, Michele, Lorigan, Paul, Chiarion-Sileni, Vanna, Gogas, Helen, Maio, Michele, Fierro, Maria Te

Journal:

European Journal of Cancer

Year:

2019

Language:

english

File:

PDF, 418 KB

english, 2019

94

Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer

Tinsley, Nadina, Zhou, Cong, Tan, Grace, Rack, Samuel, Lorigan, Paul, Blackhall, Fiona, Krebs, Matthew, Carter, Louise, Thistlethwaite, Fiona, Graham, Donna, Cook, Natalie

Journal:

Year:

2019

Language:

english

File:

PDF, 615 KB

english, 2019

95

Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019

Ugurel, Selma, RÃ¶hmel, Joachim, Ascierto, Paolo A., Becker, JÃ¼rgen C., Flaherty, Keith T., Grob, Jean J., Hauschild, Axel, Larkin, James, Livingstone, Elisabeth, Long, Georgina V., Lorigan, Paul, Mc

Journal:

European Journal of Cancer

Year:

2020

Language:

english

File:

PDF, 1.14 MB

english, 2020

96

Emergency presentations in patients treated with immune checkpoint inhibitors

Cooksley, Tim, Gupta, Avinash, Al-Sayed, Tamer, Lorigan, Paul

Journal:

European Journal of Cancer

Year:

2020

File:

PDF, 301 KB

2020

97

Nivolumab in treating advanced melanoma

Gomes, Fabio, Lorigan, Paul

Journal:

British Journal of Healthcare Management

Year:

2016

File:

PDF, 99 KB

2016

98

Emergency ambulatory outpatient management of immune-mediated hypophysitis

Cooksley, Tim, Knight, Tom, Gupta, Avinash, Higham, Claire, Lorigan, Paul, Adam, Safwaan

Journal:

Supportive Care in Cancer

Year:

2020

File:

PDF, 235 KB

2020

99

Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab

Parker, Matthew JS, Roberts, Mark E, Lorigan, Paul C, du Plessis, Daniel G, Chinoy, Hector

Journal:

BMJ Case Reports

Year:

2018

File:

PDF, 785 KB

2018